Cargando…
Inhibition of the mevalonate pathway enhances cancer cell oncolysis mediated by M1 virus
Oncolytic virus is an attractive anticancer agent that selectively lyses cancer through targeting cancer cells rather than normal cells. Although M1 virus is effective against several cancer types, certain cancer cells present low sensitivity to it. Here we identified that most of the components in...
Autores principales: | Liang, Jiankai, Guo, Li, Li, Kai, Xiao, Xiao, Zhu, Wenbo, Zheng, Xiaoke, Hu, Jun, Zhang, Haipeng, Cai, Jing, Yu, Yaya, Tan, Yaqian, Li, Chuntao, Liu, Xincheng, Hu, Cheng, Liu, Ying, Qiu, Pengxin, Su, Xingwen, He, Songmin, Lin, Yuan, Yan, Guangmei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5906622/ https://www.ncbi.nlm.nih.gov/pubmed/29670091 http://dx.doi.org/10.1038/s41467-018-03913-6 |
Ejemplares similares
-
A classical PKA inhibitor increases the oncolytic effect of M1 virus via activation of exchange protein directly activated by cAMP 1
por: Li, Kai, et al.
Publicado: (2016) -
DNA-PK inhibition synergizes with oncolytic virus M1 by inhibiting antiviral response and potentiating DNA damage
por: Xiao, Xiao, et al.
Publicado: (2018) -
Lonidamine potentiates the oncolytic efficiency of M1 virus independent of hexokinase 2 but via inhibition of antiviral immunity
por: Cai, Jing, et al.
Publicado: (2020) -
Negative regulation of miR‐1275 by H3K27me3 is critical for glial induction of glioblastoma cells
por: Mai, Jialuo, et al.
Publicado: (2019) -
Intravenous injection of the oncolytic virus M1 awakens antitumor T cells and overcomes resistance to checkpoint blockade
por: Liu, Yang, et al.
Publicado: (2020)